Every year, millions of babies around the world are screened for dozens of treatable conditions within the first day or two of life. What it takes is a few drops of blood on some filter paper, and what it gives is profound: potentially life-saving information. The advent of newborn screening is one of the greatest public achievements of the 20th century; since their earliest implementation, screening programs have diagnosed hundreds of thousands of babies early enough for medical intervention. And the life-saving potential they hold continues to grow with the development of genomic sequencing technology, which will increase the number of screenable conditions by an order of magnitude. In this episode, we explore the serendipitous origins of newborn screening, what the process looks like from a parent’s perspective, and how cutting-edge technology could revolutionize these programs. To help us navigate the exciting future of newborn screening, Dr. Joshua Milner, Professor of Pediatrics and Director of Allergy Immunology and Rheumatology at Columbia University Medical Center joins us to discuss an ambitious research program at NewYork-Presbyterian hospitals titled the GUARDIAN study, or Genomic Uniform-screening Against Rare Disease in All Newborns. Tune in for a truly thrilling episode!
For more on the GUARDIAN study, the groundbreaking research program using genomic sequencing technology to screen newborns at NewYork-Presbyterian hospitals for hundreds of conditions, check out the Advances in Care podcast episode titled “Newborn Gene Sequencing: Expanding Early Detection of Treatable Diseases.”
| History | Biology |
| Advisory Committee on Heritable Disorders in Newborns and Children Charter | Levy, P.A., 2010. An overview of newborn screening. Journal of Developmental & Behavioral Pediatrics, 31(7), pp.622-631. |
| 2025 Current Fiscal Year Report: Advisory Committee on Heritable Disorders in Newborns and Children | Berry, S.A., 2015. Newborn screening. Clinics in Perinatology, 42(2), pp.441-53. |
| Cohen, Leslie. “The de‐coders: A historical perspective of the genetic counseling profession.” Birth Defects Research 112.4 (2020): 307-315. | Ziegler, A., Koval-Burt, C., Kay, D.M., Suchy, S.F., Begtrup, A., Langley, K.G., Hernan, R., Amendola, L.M., Boyd, B.M., Bradley, J. and Brandt, T., 2025. Expanded newborn screening using genome sequencing for early actionable conditions. jama, 333(3), pp.232-240. |
| El-Hattab, Ayman W., Mohammed Almannai, and V. Reid Sutton. “Newborn screening: history, current status, and future directions.” Pediatric Clinics 65.2 (2018): 389-405. | Andermann, A., Blancquaert, I., Beauchamp, S. and Déry, V., 2008. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bulletin of the World Health Organization, 86(4), pp.317-319. |
| Gaviglio, Amy, et al. “Infants with congenital diseases identified through newborn screening—United States, 2018–2020.” International Journal of Neonatal Screening 9.2 (2023): 23. | Andermann, A., Blancquaert, I., Beauchamp, S. and Costea, I., 2010. Guiding policy decisions for genetic screening: developing a systematic and transparent approach. Public Health Genomics, 14(1), pp.9-16. |
| Guthrie, Robert. “Blood screening for phenylketonuria.” Jama 178.8 (1961): 863-863. | “Newborn Screening Information for Families: Laboratory Testing Overview-Minnesota Dept. of Health.” (2014). https://www.health.state.mn.us/people/newbornscreening/families/testing.html |
| Guthrie, R., and H. Bickel. “The introduction of newborn screening for phenylketonuria: A personal history.” European journal of pediatrics 155.Suppl 1 (1996): S4-S5. | Baby’s First Test interactive state by state map: https://babysfirsttest.org/newborn-screening/rusp-conditions |
| Promoting Safe and Effective Genetic Testing in the United States Final Report of the Task Force on Genetic Testing. Eds Neil A. Holtzman, Michael S. Watson. 1997 | HRSA: About Newborn screening. Rev March 2025. https://newbornscreening.hrsa.gov/about-newborn-screening |
| King, Jovanka R., and Lennart Hammarström. “Newborn screening for primary immunodeficiency diseases: history, current and future practice.” Journal of clinical immunology 38.1 (2018): 56-66. | NORD CEO statement on the Termination of the Advisory Committee on Heritable Disorders in Newborns and Children. April 4,2025. https://rarediseases.org/ceo-statement-on-termination-of-achdnc/ |
| Levy, Harvey L. “A life in newborn screening.” International Journal of Neonatal Screening 2.4 (2016): 14. | Gaviglio, A., McKasson, S., Singh, S. and Ojodu, J., 2023. Infants with congenital diseases identified through newborn screening—United States, 2018–2020. International Journal of Neonatal Screening, 9(2), p.23. |
| Levy, Harvey L. “Robert Guthrie and the trials and tribulations of newborn screening.” International journal of neonatal screening 7.1 (2021): 5. | Tam, P.Y.I., Padilla, C.D., Zlotkin, S., Ayede, A.I., Banu, T., Kayita, J., Khanna, R., Rao, S.P., Siddeeg, K., Walani, S. and de Costa, A., 2024. The 77th World Health Assembly resolution calling for newborn screening, diagnosis, and management of birth defects: moving towards action in low-income and middle-income countries. The Lancet Global Health, 12(11), pp.e1754-e1755. |
| McCandless, Shawn E., and Erica J. Wright. “Mandatory newborn screening in the United States: History, current status, and existential challenges.” Birth defects research 112.4 (2020): 350-366. | World Health Organization, 2024. Universal newborn screening implementation guidance. https://www.who.int/publications/i/item/9789290211389 |
| Penrose, Lionel, and Juda Hirsch Quastel. “Metabolic studies in phenylketonuria.” Biochemical Journal 31.2 (1937): 266. | NHS: Newborn Screening. https://www.nhs.uk/baby/newborn-screening/ |
| Resta, Robert G. “What have we been trying to do and have we been any good at it? A history of measuring the success of genetic counseling.” European Journal of Medical Genetics 62.5 (2019): 300-307. | Tluczek, A., Ersig, A.L. and Lee, S., 2022. Psychosocial issues related to newborn screening: a systematic review and synthesis. International Journal of Neonatal Screening, 8(4), p.53. |
| Sontag, Marci K. “Infants with congenital disorders identified through newborn screening—United States, 2015–2017.” MMWR. Morbidity and mortality weekly report 69 (2020). | Farrell, M.H., Certain, L.K. and Farrell, P.M., 2001. Genetic counseling and risk communication services of newborn screening programs. Archives of pediatrics & adolescent medicine, 155(2), pp.120-126. |
| Tarini, Beth A. “The current revolution in newborn screening: new technology, old controversies.” Archives of pediatrics & adolescent medicine 161.8 (2007): 767-772. | |
| Tluczek, Audrey, Anne L. Ersig, and Shinhyo Lee. “Psychosocial issues related to newborn screening: a systematic review and synthesis.” International Journal of Neonatal Screening 8.4 (2022): 53. | |
| Wilcken, Bridget, and Veronica Wiley. “Fifty years of newborn screening.” Journal of paediatrics and child health 51.1 (2015): 103-107. | |
| Woolf, Louis I., and John Adams. “The early history of PKU.” International journal of neonatal screening 6.3 (2020): 59. |
Disclaimer: This post may contain affiliate links. If you buy something through one of these links, you won’t pay a penny more, but we’ll get a small commission which helps us keep things running. Thanks!
